CRANIAL NERVE PARALYSIS

This adverse event was reported 474 times

These drugs are most commonly taken by patients reporting CRANIAL NERVE PARALYSIS:

# Drug Count
0 CILTACABTAGENE AUTOLEUCEL 174
1 METHOTREXATE 19
2 METHOTREXATE SODIUM 19
3 ACETAMINOPHEN 17
4 ASPIRIN 14
5 ASPIRIN 325 MG 14
6 ASPIRIN 81 MG 14
7 MYCOPHENOLATE MOFETIL 13
8 MYCOPHENOLATE MOFETIL HYDROCHLORIDE 13
9 PREDNISONE 13
See all common drugs associated with CRANIAL NERVE PARALYSIS

CRANIAL NERVE PARALYSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 CILTACABTAGENE AUTOLEUCEL 174 0.0265
1 ALUMINUM SULFATE TETRADECAHYDRATE, CALCIUM ACETATE MONOHYDRATE 1 0.0156
2 EPLONTERSEN 1 0.0057
3 1169 HYDROGEN PEROXIDE SPRAY 1 0.0032
4 HYDROGEN PEROXIDE 1 0.0030
5 IDECABTAGENE VICLEUCEL 3 0.0024
6 LISOCABTAGENE MARALEUCEL 2 0.0023
7 NIMODIPINE 2 0.0018
8 GARADACIMAB 1 0.0013
9 CALASPARGASE PEGOL 1 0.0012
See all drugs enriched for association with CRANIAL NERVE PARALYSIS

CRANIAL NERVE PARALYSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-5 Antagonist [EPC] 2 0.0029
1 CD123 Interaction [EPC] 1 0.0019
2 Prostacycline [EPC] 1 0.0011
3 Nucleoside Analog Antifungal [EPC] 1 0.0007
4 CD38-directed Cytolytic Antibody [EPC] 4 0.0007
5 Rifamycin Antimycobacterial [EPC] 2 0.0006
6 Endoglycosidase [EPC] 1 0.0005
7 Cytolytic Agent [EPC] 1 0.0004
8 Plasma Kallikrein Inhibitor [EPC] 1 0.0004
9 Ergot Derivative [EPC] 2 0.0004
See all drug classes enriched for association with CRANIAL NERVE PARALYSIS